These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1675041)

  • 1. Antagonism of vecuronium-induced neuromuscular block.
    Bentley JB; Lahet BS
    Anesthesiology; 1991 Jun; 74(6):1169-70. PubMed ID: 1675041
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism of moderate degrees of vecuronium-induced neuromuscular block by small doses of neostigmine.
    Johnson RA; Harper NJ
    Br J Anaesth; 1989 May; 62(5):483-7. PubMed ID: 2567178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of the level of paralysis recovery for a rapid antagonism of vecuronium with neostigmine in children during halothane anesthesia.
    Meistelman C; Debaene B; d'Hollander A; Donati F; Saint-Maurice C
    Anesthesiology; 1988 Jul; 69(1):97-9. PubMed ID: 2898904
    [No Abstract]   [Full Text] [Related]  

  • 4. Neostigmine antagonism of vecuronium paralysis during fentanyl, halothane, isoflurane, and enflurane anesthesia.
    Dernovoi B; Agoston S; Barvais L; Baurain M; Lefebvre R; d'Hollander A
    Anesthesiology; 1987 May; 66(5):698-701. PubMed ID: 2883916
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose-response relationships for neostigmine antagonism of vecuronium-induced neuromuscular block in adults and the elderly.
    McCarthy GJ; Cooper R; Stanley JC; Mirakhur RK
    Br J Anaesth; 1992 Sep; 69(3):281-3. PubMed ID: 1356398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of neostigmine in the antagonism of residual neuromuscular blockade produced by vecuronium.
    Jones JE; Hunter JM; Utting JE
    Br J Anaesth; 1987 Nov; 59(11):1454-8. PubMed ID: 2891365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrical and mechanical responses after neuromuscular blockade with vecuronium, and subsequent antagonism with neostigmine or edrophonium.
    Astley BA; Katz RL; Payne JP
    Br J Anaesth; 1987 Aug; 59(8):983-8. PubMed ID: 2888476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of vecuronium-induced neuromuscular block in patients pretreated with magnesium sulphate: dose-effect relationship of neostigmine.
    Fuchs-Buder T; Ziegenfuss T; Lysakowski K; Tassonyi E
    Br J Anaesth; 1999 Jan; 82(1):61-5. PubMed ID: 10325838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery from vecuronium neuromuscular blockade following neostigmine administration in infants, children, and adults during halothane anesthesia.
    Debaene B; Meistelman C; d'Hollander A
    Anesthesiology; 1989 Dec; 71(6):840-4. PubMed ID: 2574016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
    Smith CE; Donati F; Bevan DR
    Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium.
    Rupp SM; McChristian JW; Miller RD; Taboada JA; Cronnelly R
    Anesthesiology; 1986 Jun; 64(6):711-7. PubMed ID: 2872839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?
    Baurain MJ; Hoton F; D'Hollander AA; Cantraine FR
    Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
    Kirkegaard-Nielsen H; Toft P; Severinsen IK; May O
    Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of doxapram on neostigmine evoked antagonism of vecuronium neuromuscular block.
    Orlowski M; Pollard BJ
    Br J Anaesth; 1992 Apr; 68(4):418-9. PubMed ID: 1353679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery characteristics following antagonism of vecuronium with edrophonium, neostigmine or pyridostigmine.
    Yungbluth J; Henry JD; McAnallen K; Albee DT
    AANA J; 1988 Apr; 56(2):127-33. PubMed ID: 2897148
    [No Abstract]   [Full Text] [Related]  

  • 16. Antagonism of vecuronium-induced neuromuscular blockade with edrophonium or neostigmine.
    Mirakhur RK; Gibson FM; Lavery GG
    Br J Anaesth; 1987 Apr; 59(4):473-7. PubMed ID: 2882768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular blocking action of vecuronium in the dog and its reversal by neostigmine.
    Jones RS
    Res Vet Sci; 1985 Mar; 38(2):193-6. PubMed ID: 2860709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
    Fleming NW; Macres S; Antognini JF; Vengco J
    Br J Anaesth; 1996 Oct; 77(4):492-5. PubMed ID: 8942334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of vecuronium paralysis: comparison between edrophonium and neostigmine.
    Dernovoi BS
    Acta Anaesthesiol Belg; 1991; 42(1):65-71. PubMed ID: 1676233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous or neostigmine-induced recovery after maintenance of neuromuscular block with Org 9487 (rapacuronium) or rocuronium following an initial dose of Org 9487.
    McCourt KC; Mirakhur RK; Lowry DW; Carroll MT; Sparr HJ
    Br J Anaesth; 1999 May; 82(5):755-6. PubMed ID: 10536556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.